Update on Gabapentin Therapy of Neuropathic Pain

Consultant Pharmacist

Volumn 18, Issue 2, 2003, Pages 158-178

  Guay, David R P ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Health Partners   (United States)

Author keywords

Gabapentin; Neuralgia; Neuropathic pain; Neuropathy

Indexed keywords

ALUMINUM MAGNESIUM HYDROXIDE; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CLONAZEPAM; DEXTROMETHORPHAN; DOXEPIN; FENTANYL; GABAPENTIN; HYDROMORPHONE; IMIPRAMINE; LAMOTRIGINE; METHADONE; MEXILETINE; MORPHINE; MORPHINE SULFATE; NORTRIPTYLINE; OPIATE; OXYCODONE; PARACETAMOL; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT;

ANALGESIA; ANALGESIC ACTIVITY; AREA UNDER THE CURVE; ASTHENIA; ATAXIA; BALANCE DISORDER; CLINICAL TRIAL; DIABETIC NEUROPATHY; DIARRHEA; DIPLOPIA; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG CHOICE; DRUG CLEARANCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENTIATION; DRUG TOLERABILITY; DYSPHORIA; DYSURIA; EDEMA; EUPHORIA; FATIGUE; FLUSHING; HEADACHE; HUMAN; INFECTION; MONOTHERAPY; MULTIPLE SCLEROSIS; MUSCLE SPASM; NEUROPATHIC PAIN; NEUROTOXICITY; PARESTHESIA; POSTHERPETIC NEURALGIA; PRURITUS; REVIEW; SIDE EFFECT; SOMNOLENCE; SUSTAINED RELEASE PREPARATION; TREMOR; VISUAL DISORDER; VISUAL IMPAIRMENT; WEIGHT GAIN; XEROSTOMIA;

EID: 0842321975     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Guay DRP. Adjunctive agents in the management of chronic pain. Pharmacotherapy 2001;21:1070-81.
2. Guay DRP, Lackner TE, Hanlon JT. Pharmacologic management: non-invasive modalities. In Weiner DK, Herr K, Rudy TE, eds. Improving the lives of older adults with persistent pain: an interdisciplinary guide. New York: Springer; 2002.
3. Guay DRP. Lamotrigine in the treatment of neuropathic pain. Consult Pharm 2001;16:1057-67.
4. Taylor CP, Gee NS, Su T-Z et al. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Research 1998;29:233-49.
5. Attal N, Brasseur L, Parker F et al. Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: a pilot study. Eur Neurol 1998;40:191-200.
6. Eckhardt K, Ammon S, Hofmann U et al. Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg 2000;91:185-91.
7. Dirks J, Fredensborg BB, Christensen D et al. A randomized study of the effects of single-dose gabapentin versus placebo on post-operative pain and morphine consumption after mastectomy. Anesthesiology 2002;97:560-4.
8. Devulder J, Lambert J, Naeyaert JM. Gabapentin for pain control in cancer patients' wound dressing care. J Pain Symptom Manage 2001;22:622-6.
9. Behn MO, Kearns GL. Treatment of pain with gabapentin in a neonate. Pediatrics 2001;108:482-5.
10. Alam M, Rabinowitz AD, Engler DE. Gabapentin treatment of multiple piloleiomyoma-related pain. J Am Acad Dermatol 2002;46 (Suppl 2):S27-S29.
11. Benito-Leon J, Picardo A, Garrido A, Cuberas R. Gabapentin therapy for genitofemoral and ilioinguinal neuralgia [letter]. J Neurol 2001;248:907-8.
12. Ross JR, Waight C, Riley J, Broadley K. Gabapentin: resistant neuropathic pain and malignancy [letter]. Pall Med 2001;15:348-9.
13. Pelham A, Lee MA, Regnard CBF. Gabapentin for coeliec plexus pain. Pall Med 2002;16:355-6.
14. Mercadante S, Villari P, Fulfaro F. Gabapentin for opioid-related myoclonus in cancer patients. Support Care Cancer 2001;9:205-6.
15. Holtam N. Gabapentin for treatment of thalamic pain syndrome [letter]. Pall Med 2000;14:167.
16. van Deventer H, Bernard S. Use of gabapentin to treat taxane-induced myalgias [letter]. J Clin Oncol 1999;17:434-5.
17. Vadivelu N, Berger J. Neuropathic pain after anti-HIV gene therapy successfully treated with gabapentin [letter]. J Pain Symptom Manage 1999;17:155-6.
18. Filadora VA II, Sist TC, Lema MJ. Acute herpetic neuralgia and postherpetic neuralgia in the head and neck: response to gabapentin in five cases. Reg Anes Pain Med 1999;24:170-4.
19. Segal AZ, Rordorf G. Gabapentin as a novel treatment for postherpetic neuralgia. Neurology 1996;46:1175-6.
20. Sist T, Filadora V, Miner M, Lema M. Gabapentin for idiopathic trigeminal neuralgia: report of two cases. Neurology 1997;48:1467.
21. Samkoff LM, Daras M, Tuchman AJ, Koppel BS. Amelioration of refractory dysesthetic limb pain in multiple sclerosis by gabapentin. Neurology 1997;49:304-5.
22. Ness TJ, San Pedro EC, Richards JS et al. A case of spinal cord injury-related pain with baseline rCBP brain SPECT imaging and beneficial response to gabapentin. Pain 1998;78:139-43.
23. Braverman DL, Slipman CW, Lenrow DA. Using gabapentin to treat failed back surgery syndrome caused by epidural fibrosis: a report of 2 cases. Arch Phys Med Rehabil 2001;82:691-3.
24. Kapadia NP, Harden N. Gabapentin for chronic pain in spinal cord injury: a case report. Arch Phys Med Rehabil 2000;81:1439-41.
25. Hays H, Woodroffe MA. Using gabapentin to treat neuropathic pain. Can Fam Phys 1999;45:2109-12.
26. Zapp JJ. Postpoliomyelitis pain treated with gabapentin. Am Fam Phys 1996;53:2442-5.
27. McGraw T, Stacey BR. Gabapentin for treatment of neuropathic pain in a 12-year-old girl. Clin J Pain 1998;14:354-6.
28. McGraw T, Kosek P. Erythromelalgia pain managed with gabapentin. Anesthesiology 1997;86:988-90.
29. Rosner H, Rubin L, Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain 1996;12:56-8.
30. Khatri A, Pearlstein L. Pain in Guillain-Barre syndrome [letter]. Neurology 1997;49:1474.
31. Wheeler DS, Vaux KK, Tam DA. Use of gabapentin in the treatment of childhood reflex sympathetic dystrophy. Pediatr Neurol 2000;22:220-1.
32. Schacter SC, Sauter MK. Treatment of central pain with gabapentin: case reports [letter]. J Epilepsy 1996;9:223-5.
33. Lucier E, Franm L. Use of gabapentin in a case of facial neuritis [letter]. Anesth Analg 1997;85:1410.
34. Newshan G. HIV neuropathy treated with gabapentin [letter]. AIDS 1998;12:219-21.
35. Chen B, Stitik TP, Foye PM et al. Central post-stroke pain syndrome. Yet another use for gabapenrin? Am J Phys Med Rehabil 2002;81:718-20.
36. Moretti R, Torre P, Antonello RM et al. Gabapentin treatment of glossopharyngeal neuralgia: a follow-up of four years of a single case. Eur J Pain 2002;6:403-7.
37. Chandler A, Williams JE. Gabapentin, an adjuvant treatment for neuropathic pain in a cancer hospital [letter]. J Pain Symptom Manage 2000;20:82-6.
38. Solaro C, Messmer Uccelli M, Guglieri P et al. Gabapentin is effective in treating nocturnal painful spasms in multiple sclerosis. Multiple Sclerosis 2000;6:192-3.
39. Caraceni A, Zacca E, Martini C, DeConno F. Gabapentin is an adjuvant to opioid analgesia for neuropathic cancer pain. J Pain Symptom Manage 1999;17:441-5.
40. Ness TJ, Crimaldi JC, McDanal JT. Case report on gabapentin [letter]. Reg Anes Pain Med 1998;23:110-1.
41. Sist TC, Filadora VA II, Miner M, Lema M. Experience with gabapentin for neuropathic pain in the head and neck: report of ten cases. Reg Anes 1997;22:473-8.
42. Merren MD. Gabapentin for the treatment of pain and tremor: a large case series. South Med J 1998;91:739-44.
43. Putzke JD, Richards JS, Kezar L et al. Long-term use of gabapentin for treatment of pain after traumatic spinal cord injury. Clin J Pain 2002;18:118-21.
44. Ben-David B, Friedman M. Gabapentin therapy for vulvodynia. Anesth Analg 1999;89:1459-60.
45. Rosenberg JM, Harrell C, Ristic H et al. The effect of gabapentin on neuropathic pain. Clin J Pain 1997;13:251-5.
46. Mellick GA, Mellicy LB. Gabapentin in the management of reflex sympathetic dystrophy [letter]. J Pain Symptom Manage 1995;10:265-6.
47. Epstein B, Childers MK. The use of gabapentin for neuropathic and musculoskeletal pain: a case series. J Neuro Rehab 1998;12:81-6.
48. Solaro C, Lunardi GL, Capello E et al. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology 1998;51:609-11.
49. Khan OA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology 1998;51:611-4.
50. Mellick LB, Mellick GA. Successful treatment of reflex sympathetic dystrophy with gabapentin [letter]. Am J Emerg Med 1995;13:96.
51. Solaro C, Uccelli MM, Uccelli A et al. Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. Eur Neurol 2000;44:45-8.
52. Bosnjak S, Jelic S, Susnjar S, Lukic V. Gabapentin for relief of neuropathic pain related to anticancer treatment. J Chemother 2002;14:214-9.
53. To T-P, Lim TC, Hill ST et al. Gabapentin for neuropathic pain following spinal cord injury. Spinal Cord 2002;40:282-5.
54. Rice ASC, Maton S. Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomized, double-blind, placebo controlled study. Pain 2001;94:215-24.
55. Rowbotham M, Harden N, Stacey B et al. Gabapentin Postherpetic Neuralgia Study Group. Gabapentin for the treatment of postherpetic neuralgia. JAMA 1998;280:1837-42.
56. Perez HET, Sanchez GE. Gabapentin therapy for diabetic neuropathic pain [letter]. Am J Med 2000;108:689.
57. Gorson KC, Schott C, Herman R et al. Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial [letter]. J Neurol Neurosurg Psych 1999;66:251-2.
58. Backonja M, Beydoun A, Edwards KR et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 1998;280:1831-6.
59. Dallocchio C, Buffa C, Mazzarello P, Chiroli S. Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study. J Pain Symptom Manage 2000;20:280-5.
60. Morello CM, Leckband SG, Stoner CP et al. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999;159:1931-7.
61. Mueller ME, Gruenthal M, Olson WL, Olson WH. Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis. Arch Phys Med Rehabil 1997;78:521-4.
62. Mellegers MA, Furlan AD, Mailis A. Gabapentin for neuropathic pain: systematic review of controlled and uncontrolled literature. Clin J Pain 2001;17:284-95.
63. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. Br Med J 1995;310:452-4.
64. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999;83:389-400.
65. Collins SL, Moore A, McQuay HJ, Wiffen P. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: quantitative systematic review. J Pain Symptom Manage 2000;20:449-58.
66. Pfizer Inc. Neurontin® (gabapentin) package insert. New York: May 2002.